
Kaipeen E. Yang
Examiner (ID: 12300, Phone: (571)270-7178 , Office: P/1675 )
| Most Active Art Unit | 1675 |
| Art Unit(s) | 1675, 1654 |
| Total Applications | 445 |
| Issued Applications | 338 |
| Pending Applications | 0 |
| Abandoned Applications | 110 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9739576
[patent_doc_number] => 20140275295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'METHOD FOR TREATING TYPE I AND TYPE II DIABETES'
[patent_app_type] => utility
[patent_app_number] => 14/352439
[patent_app_country] => US
[patent_app_date] => 2012-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6233
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14352439
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/352439 | METHOD FOR TREATING TYPE I AND TYPE II DIABETES | Oct 18, 2012 | Abandoned |
Array
(
[id] => 10169334
[patent_doc_number] => 09200035
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-01
[patent_title] => 'Bifunctional compounds'
[patent_app_type] => utility
[patent_app_number] => 14/352891
[patent_app_country] => US
[patent_app_date] => 2012-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 47
[patent_no_of_words] => 24324
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14352891
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/352891 | Bifunctional compounds | Oct 18, 2012 | Issued |
Array
(
[id] => 10083507
[patent_doc_number] => 09120846
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-01
[patent_title] => 'Neutral zwitterionic displacer molecules for hydrophobic displacement chromatography'
[patent_app_type] => utility
[patent_app_number] => 14/349102
[patent_app_country] => US
[patent_app_date] => 2012-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18447
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 219
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14349102
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/349102 | Neutral zwitterionic displacer molecules for hydrophobic displacement chromatography | Oct 2, 2012 | Issued |
Array
(
[id] => 9772822
[patent_doc_number] => 20140296485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'ANIONIC DISPLACER MOLECULES FOR HYDROPHOBIC DISPLACEMENT CHROMATOGRAPHY'
[patent_app_type] => utility
[patent_app_number] => 14/349092
[patent_app_country] => US
[patent_app_date] => 2012-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 24495
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14349092
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/349092 | ANIONIC DISPLACER MOLECULES FOR HYDROPHOBIC DISPLACEMENT CHROMATOGRAPHY | Oct 2, 2012 | Abandoned |
Array
(
[id] => 10361152
[patent_doc_number] => 20150246157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-03
[patent_title] => 'SCAFFOLD FOR CARDIAC PATCH'
[patent_app_type] => utility
[patent_app_number] => 14/429683
[patent_app_country] => US
[patent_app_date] => 2012-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 8471
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14429683
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/429683 | Scaffold for cardiac patch | Sep 20, 2012 | Issued |
Array
(
[id] => 10946896
[patent_doc_number] => 20140349918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-27
[patent_title] => 'DERIVATIVES OF XANTHONE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/343818
[patent_app_country] => US
[patent_app_date] => 2012-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 18591
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343818
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/343818 | DERIVATIVES OF XANTHONE COMPOUNDS | Sep 9, 2012 | Abandoned |
Array
(
[id] => 10926968
[patent_doc_number] => 20140329989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-06
[patent_title] => 'PREPARATION OF MICAFUNGIN INTERMEDIATES'
[patent_app_type] => utility
[patent_app_number] => 14/241472
[patent_app_country] => US
[patent_app_date] => 2012-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25947
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14241472
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/241472 | PREPARATION OF MICAFUNGIN INTERMEDIATES | Sep 6, 2012 | Abandoned |
Array
(
[id] => 9806324
[patent_doc_number] => 20150018269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-15
[patent_title] => 'STRUCTURAL MIMETICS OF PROLINE-RICH PEPTIDES AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/241245
[patent_app_country] => US
[patent_app_date] => 2012-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16373
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14241245
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/241245 | Structural mimetics of proline-rich peptides and use thereof | Aug 23, 2012 | Issued |
Array
(
[id] => 11773453
[patent_doc_number] => 09382292
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-05
[patent_title] => 'Cyclic tetrapeptides and therapeutic applications thereof'
[patent_app_type] => utility
[patent_app_number] => 13/593716
[patent_app_country] => US
[patent_app_date] => 2012-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 35
[patent_no_of_words] => 26035
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13593716
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/593716 | Cyclic tetrapeptides and therapeutic applications thereof | Aug 23, 2012 | Issued |
Array
(
[id] => 9762290
[patent_doc_number] => 08846614
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-30
[patent_title] => 'Process for the synthesis of 37-mer peptide pramlintide'
[patent_app_type] => utility
[patent_app_number] => 13/591647
[patent_app_country] => US
[patent_app_date] => 2012-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 8400
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13591647
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/591647 | Process for the synthesis of 37-mer peptide pramlintide | Aug 21, 2012 | Issued |
Array
(
[id] => 8649562
[patent_doc_number] => 20130035292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-07
[patent_title] => 'NMDA Receptors Modulators and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/525861
[patent_app_country] => US
[patent_app_date] => 2012-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19737
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13525861
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/525861 | NMDA receptors modulators and uses thereof | Jun 17, 2012 | Issued |
Array
(
[id] => 8792645
[patent_doc_number] => 20130109614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-02
[patent_title] => 'ANTAGONISTS FOR DISEASES INDUCED BY CELLS WITH HIGH-AFFINITY ELR-CXC CHEMOKINE RECEPTOR PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 13/494587
[patent_app_country] => US
[patent_app_date] => 2012-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3369
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13494587
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/494587 | Antagonists for diseases induced by cells with high-affinity ELR-CXC chemokine receptor proteins | Jun 11, 2012 | Issued |
Array
(
[id] => 9756287
[patent_doc_number] => 20140286988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'HYDRAZINO 1H-IMIDAZOQUINOLIN-4-AMINES AND CONJUGATES MADE THEREFROM'
[patent_app_type] => utility
[patent_app_number] => 14/123718
[patent_app_country] => US
[patent_app_date] => 2012-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17212
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14123718
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/123718 | Hydrazino 1H-imidazoquinolin-4-amines and conjugates made therefrom | May 31, 2012 | Issued |
Array
(
[id] => 9656311
[patent_doc_number] => 20140227317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'HETEROBIFUNCTIONAL LINKERS WITH POLYETHYLENE GLYCOL SEGMENTS AND IMMUNE RESPONSE MODIFIER CONJUGATES MADE THEREFROM'
[patent_app_type] => utility
[patent_app_number] => 14/123727
[patent_app_country] => US
[patent_app_date] => 2012-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18196
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14123727
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/123727 | Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom | May 31, 2012 | Issued |
Array
(
[id] => 9932368
[patent_doc_number] => 20150080559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-19
[patent_title] => 'Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acid Linked Dolastatin Derivatives'
[patent_app_type] => utility
[patent_app_number] => 14/122667
[patent_app_country] => US
[patent_app_date] => 2012-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 53020
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14122667
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/122667 | Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acid Linked Dolastatin Derivatives | May 23, 2012 | Abandoned |
Array
(
[id] => 10149029
[patent_doc_number] => 09181304
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-10
[patent_title] => 'Macrocyclic therapeutic agents and methods of treatment'
[patent_app_type] => utility
[patent_app_number] => 14/118513
[patent_app_country] => US
[patent_app_date] => 2012-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9825
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14118513
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/118513 | Macrocyclic therapeutic agents and methods of treatment | May 16, 2012 | Issued |
Array
(
[id] => 13222813
[patent_doc_number] => 10125171
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-13
[patent_title] => Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
[patent_app_type] => utility
[patent_app_number] => 14/116591
[patent_app_country] => US
[patent_app_date] => 2012-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 37466
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 268
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14116591
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/116591 | Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof | May 10, 2012 | Issued |
Array
(
[id] => 8496424
[patent_doc_number] => 20120295832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => 'Novel Lipids and Compositions for Intracellular Delivery of Biologically Active Compounds'
[patent_app_type] => utility
[patent_app_number] => 13/466640
[patent_app_country] => US
[patent_app_date] => 2012-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 16528
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13466640
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/466640 | Lipids and compositions for intracellular delivery of biologically active compounds | May 7, 2012 | Issued |
Array
(
[id] => 9250510
[patent_doc_number] => 08614289
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-24
[patent_title] => 'Processes for the manufacture of macrocyclic depsipeptides and new intermediates'
[patent_app_type] => utility
[patent_app_number] => 13/449937
[patent_app_country] => US
[patent_app_date] => 2012-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22893
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13449937
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/449937 | Processes for the manufacture of macrocyclic depsipeptides and new intermediates | Apr 17, 2012 | Issued |
Array
(
[id] => 9009361
[patent_doc_number] => 08524659
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-03
[patent_title] => 'RNA virus-derived peptides with modified side chains'
[patent_app_type] => utility
[patent_app_number] => 13/440101
[patent_app_country] => US
[patent_app_date] => 2012-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 9
[patent_no_of_words] => 12600
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13440101
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/440101 | RNA virus-derived peptides with modified side chains | Apr 4, 2012 | Issued |